Active

Developing ultra-sensitive MRI that spots cancer sooner

Cancer types:

Breast cancer

Project period:

Research institute:

Deutsches Krebsforschungszentrum

Award amount:

£212,300

Location:

Germany

Researcher Dr Leif Schröder

Dr Leif Schröder and his team are trying to improve ways of spotting cancer that has spread to the lungs to help patients sooner and give them better treatment options.

Hope for the future

Catching cancer early can give a patient the best chance of survival, especially when it spreads to other parts of the body. Cancer often spreads to the lungs, and an MRI scan can be used to look for tumours. However, current methods are not able to see tumours early on because they are too small to detect.

Meet the scientist

Dr Leif Schröder likes to take part in science outreach activities with the public and makes illustrations for those events. He also enjoys history documentaries, opera, classical music, and spending time in the south of France where he can use his photography skills and explore local wineries.

The science

Breast cancer is a type of cancer which commonly spreads to the lungs as the disease progresses. MRI is an effective imaging method to help spot tumours in the lungs, but current methods are not able to spot them at the earliest stage as MRI cannot see things below a certain size.


Dr Schröder and his team aim to combine recent knowledge from MRI physics and bioengineering to improve how specific and sensitive MRI scans are. The researchers will combine smart ‘nanoparticles’ and xenon gas, which will work together to highlight tumours in the lungs, together with another technique called hyperpolarisation that makes MRI scans more sensitive. Their previous research shows that this can result in much higher quality images, which could allow for earlier detection of cancer in the lungs. The team will use mice with breast cancer and use this new MRI scan to look for lung tumours at an early stage.

True breakthroughs often come from ideas that are a little hidden and that nobody really had on their radar. The overall aim might be clear, but the path can still contain mysteries that reveal truly new concepts once they are understood.

Dr Leif Schröder

Related projects

Complete France

Breast cancer

Can AI predict which patients will become resistant to treatment?

Researchers hope to find better, more personalised treatments for breast cancer patients by identifying characteristics that predict how a tumour will behave.

Researcher: Dr Anne Vincent-Salomon

Using AI to predict drug resistance mutations in breast cancer

Active Spain

Breast cancer

How does a faulty BRCA2 gene cause breast cancer to develop?

The team hope that by understanding how different mutations contribute to breast cancer, they can reveal new ways to prevent, diagnose and treat it.  

Researcher: Dr Aura Carreira

Uncovering how a faulty BRCA2 gene causes breast cancer to develop

Active Sweden

Multiple cancers

How does ‘tissue stiffening’ affect cancer development?

This project hopes to discover more about the biology of how solid tumours develop to find new ways to prevent, diagnose or treat these cancers.

Researcher: Professor Staffan Stromblad

Understanding how 'tissue stiffening' affects cancer development
Share this page